Skip to main content
URGN logo

URGN · UroGen Pharma Ltd. · Proposed Sales

Track URGN — free
$29.79 -0.08 (-0.27%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.46B
Shares
49.05M
Volume · Nov 18 1.14M Avg daily vol (3M) 1.09M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-09 Christopher Degnan 2,202
2026-09-09 Mark Schoenberg 871
2026-09-09 Jason Smith 1,519
2026-08-20 Schoenberg Mark 60,677
2026-07-09 Schoenberg Mark 10,000
2026-06-22 Schoenberg Mark 10,000
2026-06-09 Schoenberg Mark 5,222
2026-05-08 Schoenberg Mark 10,000
2026-02-03 Schoenberg Mark 13,333
2025-11-19 Schoenberg Mark 10,000
2025-09-09 Schoenberg Mark 871
2025-09-09 Smith Jason Drew 1,520
2025-07-29 Schoenberg Mark 5,149
2025-07-29 Smith Jason Drew 7,522
2025-06-10 Schoenberg Mark 5,162
2024-09-10 Schoenberg Mark 859
2024-06-11 Schoenberg Mark 5,153
2024-03-18 Schoenberg Mark 12,000
2024-02-01 Schoenberg Mark 3,789
2024-02-01 Smith Jason Drew 4,993
Showing 1–20 of 20 filings
Key facts CIK 1668243 CUSIP M96088105 13F (30d) 229 filings 213 filers Visit website Investor relations